valdecoxib has been researched along with Sensitivity and Specificity in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, C; Jia, Y; Jin, X; Liu, Y; Wang, G; Yao, L; Zhang, J; Zhou, F | 1 |
| Fang, M; He, Z; Li, P; Liu, M; Liu, X; Sun, B; Sun, J; Sun, M; Sun, Y; Wang, Y; Yu, Q; Zhang, P; Zhu, M | 1 |
| Del Carlo, S; Giorgi, M; Macchia, M; Manera, C; Saba, A; Saccomanni, G | 1 |
| Breau, AP; Fast, DM; Zhang, JY | 1 |
| Koteshwara, M; Ramakrishna, NV; Vishwottam, KN; Wishu, S | 1 |
| Brune, K; Hinz, B; Lambrecht, C; Werner, D; Werner, U | 1 |
| Meena, S; Nagaraju, D; Rao, AR; Rao, RN | 1 |
| Bey, M; Kohles, JD; Pan, S; Sanner, KM; Schachtel, BP; Schachtel, EP | 1 |
1 trial(s) available for valdecoxib and Sensitivity and Specificity
| Article | Year |
|---|---|
Utility and sensitivity of the sore throat pain model: results of a randomized controlled trial on the COX-2 selective inhibitor valdecoxib.
Topics: Adolescent; Adult; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Models, Biological; Pain; Pain Measurement; Pharyngitis; Sensitivity and Specificity; Sulfonamides | 2007 |
7 other study(ies) available for valdecoxib and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice.
Topics: Animals; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 Enzyme System; Drug Monitoring; Female; Humans; Isoxazoles; Mice; Mice, Inbred BALB C; Neoplasms; Oxazoles; Prodrugs; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfonamides; Tandem Mass Spectrometry; Xenograft Model Antitumor Assays | 2018 |
Simultaneous determination of parecoxib sodium and its active metabolite valdecoxib in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study after intravenous and intramuscular administration.
Topics: Administration, Intravenous; Animals; Chromatography, High Pressure Liquid; Injections, Intramuscular; Isoxazoles; Linear Models; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Tandem Mass Spectrometry | 2016 |
Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology.
Topics: Animals; Chromatography, High Pressure Liquid; Cyclooxygenase 2 Inhibitors; Dogs; Isoxazoles; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfonamides | 2011 |
Determination of valdecoxib and its metabolites in human urine by automated solid-phase extraction-liquid chromatography-tandem mass spectrometry.
Topics: Automation; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Humans; Isoxazoles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfonamides | 2003 |
Quantitation of Valdecoxib in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection using liquid-liquid extraction.
Topics: Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Humans; Isoxazoles; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulfonamides | 2004 |
A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma.
Topics: Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Etoricoxib; Humans; Isoxazoles; Male; Mass Spectrometry; Pyridines; Sensitivity and Specificity; Sulfonamides; Sulfones | 2005 |
Development and validation of a reversed-phase liquid chromatographic method for separation and simultaneous determination of COX-2 inhibitors in pharmaceuticals and its application to biological fluids.
Topics: Butanones; Celecoxib; Chromatography, Liquid; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Lactones; Nabumetone; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Sulfones | 2005 |